Actively Recruiting
Virtual Incentive Treatment for Alcohol
Led by Washington State University · Updated on 2025-05-30
200
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
Sponsors
W
Washington State University
Lead Sponsor
T
The University of Texas Health Science Center at San Antonio
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adults with AUD (n=200), recruited via online platforms by randomizing individuals to six months of 1) an online cognitive behavioral therapy for AUD (CBT4CBT) and telehealth PEth-based CM (CM condition) or 2) CBT4CBT and reinforcers for submitting blood samples (no abstinence required) (control condition). Investigators will assess group differences in PEth-defined abstinence and regular excessive drinking (PEth \>= 200 ng/mL), and alcohol-related harms (e.g., smoking, drug use). This study will address important gaps in CM research by assessing outcomes during a 12-month follow-up, which is much longer than most previous CM studies; using a conceptual model to identify predictors of post-treatment abstinence. Investigators will conduct an economic analysis to place the cost of this model in the context of downstream CM-associated cost-offsets and improvements in personal and public health.
CONDITIONS
Official Title
Virtual Incentive Treatment for Alcohol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Had 2 heavy drinking episodes (more than 4 drinks for assigned males or 3 drinks for assigned females) or 14 or more standard drinks in the prior 14 days, verified by a PEth biomarker over 20 ng/mL
- Have a current diagnosis of Alcohol Use Disorder based on DSM-5
- Are not currently receiving treatment for Alcohol Use Disorder
- Able to complete virtual study visits via Zoom
You will not qualify if you...
- Current diagnosis of severe substance use disorder other than Alcohol Use Disorder, tobacco, or cannabis
- PEth biomarker of 20 ng/mL or less, indicating no heavy drinking in the past month
- Unable to provide informed consent based on assessment tools
- History of alcohol withdrawal-related seizure or hospitalization in the past 12 months
- Medically or psychiatrically unsafe to participate as determined by the study investigator
- Currently enrolled in alcohol treatment or another alcohol treatment study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington State University
Spokane, Washington, United States, 99201
Actively Recruiting
Research Team
R
Rachael M Beck, BS
CONTACT
J
Julianne Jett, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here